local_hospital

Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocion De La Salud Y La C

Address
Carretera Canyet S/n, 08916 Badalona, Spain

FLS Foundation - HIV and Infectious Diseases Research Center

The FLS Foundation (Fundación FLS de Lucha Contra el SIDA las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia) is a specialized research institution dedicated to advancing the fight against HIV/AIDS and infectious diseases while promoting health and scientific innovation. The center focuses on developing novel therapeutic approaches for people living with HIV, with particular expertise in evaluating innovative treatments that address viral reservoir persistence and chronic inflammation in individuals receiving antiretroviral therapy.

  • HIV-1 reservoir reduction strategies and cure research
  • Pharmacodynamic studies of immunomodulatory agents in HIV-positive populations
  • Safety and tolerability assessments of novel therapeutic interventions for people with HIV on suppressive antiretroviral therapy

The foundation conducts cutting-edge clinical trials investigating JAK-STAT pathway inhibition and cell survival mechanisms in HIV-infected individuals. Their research aims to understand how targeted immunomodulation can impact both viral persistence and inflammation in people with HIV, contributing to the development of functional cure strategies and improved long-term health outcomes for this patient population.

Site Overview

assignment
3
connected trials
corporate_fare
2
sponsors
science
3
IMPs

Activity Indicator

Last 6 months

0
Trials started
-100% vs previous period.
1
Trials started 6–12 months ago
3
Total trials linked
Moderately Active
trending_downDeclining-100%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
2
Sponsors (total)
2
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 567 other sites in Spain

description
Trial volume
3
Outperforms 58% of sites
public
Therapeutic diversity
1areas
Outperforms 1% of sites
groups
Sponsor diversity
2sponsors
Outperforms 49% of sites

Therapeutic Area Benchmark — Spain

Select a therapeutic area to compare against other sites in Spain.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Spain

Market Share

Country: Spain

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocion De La Salud Y La C

lock Showing 1 of 3 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Evaluation of Baricitinib on HIV-1 Reservoir and Safety in Virologically Suppressed Patients with HIV-1Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocion De La Salud Y La CienciaPhase IINot RecruitingSep 2025

IMP list

lock Showing 1 of 3 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Baricitinib1Unknown2025-09-172025-09-17

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.